NCT07922330: A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
- State
- Not started
- Phase
- Phase 3
- People
- 330 planned
- Started
- 4 Jan 2027
- Primary completion
- 15 Sep 2028
- Arms
- AZD6234 Higher Target-Dose, AZD6234 Lower Target-Dose
- Results
- None posted
- 6 Nov 2026: Trial registered